How Finley was paid
$813,000 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Incentive | Total |
|---|---|---|---|
| J.D. FinleyChief Executive Officer and Chief Financial Officer | $542,000 | $271,000 | $813,000 |
| Mitchell Jones, M.D., Ph.D.Chief Medical Officer | $415,000 | $166,000 | $581,000 |
What changed and why
- $813K$813,000 was J.D. Finley’s 2024 total compensation, down from $1,277,100 in 2023.
- $581K$581,000 was Mitchell Jones’s 2024 total compensation, up from $458,024 in 2023.
- 100%100% of corporate performance targets were achieved for the 2024 annual cash incentives.
- 2024 cash incentives reflected clinical development, financial position, and corporate operations targets.
- 50%50% was Finley’s 2024 target bonus percentage; Jones’s target was 40%.
- $575K$575,000 and $440,000 were the executives’ respective base salaries effective January 1, 2025.
Other Palisade Bio proxy statements
- 2026 proxy statement
J.D. Finley paid $18.8M.
Filed Apr 29, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.